Citadel Advisors - AVALO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Citadel Advisors ownership history of AVALO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$44,000
+100.0%
88,974
+205.1%
0.00%
Q1 2022$22,000
-82.4%
29,159
-60.3%
0.00%
Q4 2021$125,000
-0.8%
73,528
+27.7%
0.00%
Q3 2021$126,00057,5590.00%
Other shareholders
AVALO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 47,576,000$23,788,0000.42%
Nantahala Capital Management 6,710,327$3,355,0000.17%
Opaleye Management Inc. 450,000$225,0000.10%
Point72 Asset Management, L.P. 6,008,850$3,004,0000.01%
Minot Wealth Management LLC 34,645$17,0000.00%
Ergoteles LLC 284,569$142,0000.00%
Y-Intercept (Hong Kong) Ltd 26,079$13,0000.00%
Mayflower Financial Advisors, LLC 10,000$5,0000.00%
MEEDER ASSET MANAGEMENT INC 18,082$9,0000.00%
Orion Portfolio Solutions, LLC 25,476$13,0000.00%
View complete list of AVALO THERAPEUTICS INC shareholders